Exosome engineering in cell therapy and drug delivery
- PMID: 36609717
- PMCID: PMC9823267
- DOI: 10.1007/s10787-022-01115-7
Exosome engineering in cell therapy and drug delivery
Abstract
Cell-derived exosomes have opened new horizons in modern therapy for advanced drug delivery and therapeutic applications, due to their key features such as low immunogenicity, high physicochemical stability, capacity to penetrate into tissues, and the innate capacity to communicate with other cells over long distances. Exosome-based liquid biopsy has been potentially used for the diagnosis and prognosis of a range of disorders. Exosomes deliver therapeutic agents, including immunological modulators, therapeutic drugs, and antisense oligonucleotides to certain targets, and can be used as vaccines, though their clinical application is still far from reality. Producing exosomes on a large-scale is restricted to their low circulation lifetime, weak targeting capacity, and inappropriate controls, which need to be refined before being implemented in practice. Several bioengineering methods have been used for refining therapeutic applications of exosomes and promoting their effectiveness, on the one hand, and addressing the existing challenges, on the other. In the short run, new diagnostic platforms and emerging therapeutic strategies will further develop exosome engineering and therapeutic potential. This requires a thorough analysis of exosome engineering approaches along with their merits and drawbacks, as outlined in this paper. The present study is a comprehensive review of novel techniques for exosome development in terms of circulation time in the body, targeting capacity, and higher drug loading/delivery efficacies.
Keywords: Cargo incorporation; Exosome; Extracellular vesicles; Targeted delivery; Therapeutic applications.
© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose and declare no conflict of interest.
Figures



Similar articles
-
Engineering Approaches for Exosome Cargo Loading and Targeted Delivery: Biological versus Chemical Perspectives.ACS Biomater Sci Eng. 2024 Oct 14;10(10):5960-5976. doi: 10.1021/acsbiomaterials.4c00856. Epub 2024 Jun 28. ACS Biomater Sci Eng. 2024. PMID: 38940421 Review.
-
Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.Int J Nanomedicine. 2023 Dec 23;18:7923-7940. doi: 10.2147/IJN.S444582. eCollection 2023. Int J Nanomedicine. 2023. PMID: 38152837 Free PMC article. Review.
-
Exosome engineering for efficient and targeted drug delivery: Current status and future perspective.J Physiol. 2023 Nov;601(22):4853-4872. doi: 10.1113/JP282799. Epub 2022 Jun 2. J Physiol. 2023. PMID: 35570717 Review.
-
Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.Int J Mol Sci. 2020 Dec 22;22(1):14. doi: 10.3390/ijms22010014. Int J Mol Sci. 2020. PMID: 33374978 Free PMC article. Review.
-
Exosome-Based Drug Delivery: Translation from Bench to Clinic.Pharmaceutics. 2023 Jul 29;15(8):2042. doi: 10.3390/pharmaceutics15082042. Pharmaceutics. 2023. PMID: 37631256 Free PMC article. Review.
Cited by
-
Schwann Cell-Derived Exosomal Vesicles: A Promising Therapy for the Injured Spinal Cord.Int J Mol Sci. 2023 Dec 10;24(24):17317. doi: 10.3390/ijms242417317. Int J Mol Sci. 2023. PMID: 38139147 Free PMC article. Review.
-
Exosomal noncoding RNA: A potential therapy for retinal vascular diseases.Mol Ther Nucleic Acids. 2024 Jan 24;35(1):102128. doi: 10.1016/j.omtn.2024.102128. eCollection 2024 Mar 12. Mol Ther Nucleic Acids. 2024. PMID: 38356865 Free PMC article. Review.
-
Research progress of exosomes from different sources in myocardial ischemia.Front Cardiovasc Med. 2024 Sep 12;11:1436764. doi: 10.3389/fcvm.2024.1436764. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39350967 Free PMC article. Review.
-
Research Advances of Engineered Exosomes as Drug Delivery Carrier.ACS Omega. 2023 Nov 9;8(46):43374-43387. doi: 10.1021/acsomega.3c04479. eCollection 2023 Nov 21. ACS Omega. 2023. PMID: 38027310 Free PMC article. Review.
-
Integrating Mitochondrial Biology into Innovative Cell Therapies for Neurodegenerative Diseases.Brain Sci. 2024 Sep 5;14(9):899. doi: 10.3390/brainsci14090899. Brain Sci. 2024. PMID: 39335395 Free PMC article. Review.
References
-
- Ahmad M, Minhas MU, Sohail M, Faisal M, Rashid H. Comprehensive review on magnetic drug delivery systems: a novel approach for drug targeting. J Pharm Altern Med. 2013;2(4):13–21.
-
- Akuma P, Okagu OD, Udenigwe CC. Naturally occurring exosome vesicles as potential delivery vehicle for bioactive compounds. Front Sustain Food Syst. 2019;3:23. doi: 10.3389/fsufs.2019.00023. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources